Biological markers for early detection and pharmacological treatment of Alzheimer's disease

The introduction of biological markers in the clinical management of Alzheimer's disease (AD) will not only improve diagnosis relating to early detection of neuropathology with underlying molecular mechanisms, but also provides tools for the assessment of objective treatment benefits. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hampel, Harald, Broich, Karl, Hoessler, Yvonne, Pantel, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2009
Materias:
Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181918/
https://www.ncbi.nlm.nih.gov/pubmed/19585950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181918/
https://www.ncbi.nlm.nih.gov/pubmed/19585950

Ejemplares similares